Sarah has worked in investment management for over 23 years. Prior to Crito Capital, Sarah ran Beckside Capital, a consulting company. Prior to Beckside, Sarah worked with Apogee Global Advisors, a precious metals fund, where she was responsible for fund raising. Prior to Apogee, she was Vice President of Marketing and Investor Relations for Lincoln Vale, LLC, a global alternative investment management firm focusing on niche hedge funds and private equity funds. Prior to this role, Sarah was a partner in Blue Dragon Capital - a copper arbitrage trading fund. Before her work with Blue Dragon, she was a Vice President at Hong Kong and Shanghai Banking Corporation both in New York and London, where she developed investment portfolios for high net worth clients. Sarah is an Advisory Board Member of a biotech company, MyoSyntax. She earned a Bachelor of Arts degree in Economics from De Montfort University in the United Kingdom.